Human T-lymphotropic virus kind 1 (HTLV-1) provirus expression is especially directed by Tax-responsive components (TRE) inside the lengthy terminal repeats (LTR). Mutations in TRE can cut back provirus expression and since a excessive proviral load (PVL) is a danger issue for the event of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), we evaluated polymorphisms within the 5′ LTR and the affiliation with PVL and illness development.
HTLV-1 LTR and tax sequences derived from asymptomatic carriers (AC) and HAM/TSP sufferers adopted in a longitudinal examine had been analysed based on PVL and medical severity. People contaminated with HTLV-1 presenting the canonical TRE, contemplating pressure ATK-1 because the consensus, displayed sustained larger PVL. In contrast, an LTR A125G mutation in TRE was related to barely diminished PVL solely in HAM/TSP sufferers, though it didn’t affect the pace of illness development.
Furthermore, this polymorphism was frequent in Latin American strains of the HTLV-1 Cosmopolitan Transcontinental subtype. Due to this fact, polymorphisms within the 5′ TRE of HTLV-1 could symbolize one of many components influencing PVL in HAM/TSP sufferers, particularly within the Latin American inhabitants. Certainly, larger PVL within the peripheral blood has been related to an elevated inflammatory exercise within the spinal twine and to a poorer prognosis in HAM/TSP. Nevertheless, this occasion was not related to TRE polymorphisms.
HTLV-1 encephalitis
A 53-year-old lady developed subacute onset of higher limb weak point, sensory loss and cerebellar dysfunction. She was recognized to have human T-lymphotropic virus kind 1 (HTLV-1)-associated myelopathy. MR scan of the mind confirmed intensive T2 hyperintensity inside the deep and subcortical white matter, with punctate distinction enhancement.
Cerebrospinal fluid (CSF) was lymphocytic with very excessive ranges of HTLV-1 provirus in each CSF and peripheral blood lymphocytes. We identified HTLV-1 encephalomyelitis and began high-dose methylprednisolone adopted by a gradual corticosteroid taper. She recovered effectively and regained practical independence within the higher limbs.
Neurological manifestations of HTLV-1 an infection lengthen past classical ‘tropical spastic paraparesis’ and are under-recognised. We assessment the literature on HTLV-1 encephalitis and focus on its prognosis and administration.
HTLV-1 an infection in acute t- lymphocytic leukemia/lymphoma
Grownup T- lymphocyte leukemia/ lymphoma (ATLL), described by Uchiyama et al. in 1977, is a definite neoplasia of peripheral T-lymphocytes attributable to human T-cell lymphotropic virus kind 1 (HTLV-1). The authors describe the case of a 75-year-old feminine affected person who offered with fever, chills, and altered psychological standing.
The peripheral blood morphology confirmed massive atypical lymphocytes with multilobed nuclei and circulate cytometry per ATLL. The authors focus on the pathophysiology, differential prognosis, and subtypes of ATLL along with the diagnostic method utilizing circulate cytometry when bone marrow biopsy is just not accessible and modalities of therapy.
Involvement of EZH2 inhibition in lenalidomide and pomalidomide-mediated progress suppression in HTLV-1-infected cells
Immunomodulatory imide medication (IMiDs), akin to lenalidomide and pomalidomide, exert pleiotropic results, e.g., antitumor results in a number of myeloma, by binding the protein Cereblon and altering its substrate specificity.
Lenalidomide is authorised for the therapy of grownup T-cell leukemia/lymphoma (ATL) attributable to human T-cell leukemia virus kind 1 (HTLV-1), though the exact mechanisms accountable for its effectiveness haven’t been totally elucidated.
Right here, we used HTLV-1-infected cell traces to research how IMiDs exert anti-ATL results. In three of 4 examined HTLV-1-infected cell traces, the cells handled with lenalidomide or pomalidomide exhibited gentle progress suppression with out apoptosis, which was related to decreased IRF4, c-Myc, and phosphorylated STAT3 ranges in addition to enhanced SOCS3 expression. Moreover, the degrees of enhancer of zeste homolog 2 (EZH2) and trimethyl histone three Lys27 (H3K27me3) had been decreased following IMiD therapy in all three vulnerable cell traces.
An IMiD-mediated discount of EZH2 and H3K27me3 ranges was additionally noticed in a a number of myeloma cell line. Moreover, therapy with an EZH2-inhibitor reproduced the IMiD-mediated results in HTLV-1-infected cells and a number of myeloma cells. These findings strongly recommend {that a} discount of EZH2 expression is concerned within the mechanism underlying the antitumor results of IMiD.
HTLV-2 Encoded Antisense Protein APH-2 Suppresses HIV-1 Replication
Antisense protein of Human T-cell Leukemia Virus Sort 2 (HTLV-2), additionally referred to as APH-2, negatively regulates the HTLV-2 and helps the virus to keep up latency through scheming the transcription. Regardless of the outstanding prevalence of HTLV-2/HIV-1 co-infection, the function of APH-2 influencing HIV-1 replication kinetics is poorly understood and wishes investigation.
On this examine, we investigated the believable function of APH-2 regulating HIV-1 replication. Herein, we report that the overexpression of APH-2 not solely hampered the discharge of HIV-1 pNL4.three from 293T cells in a dose-dependent method but in addition affected the mobile gag expression. The same and constant impact of APH-2 overexpression was additionally noticed in case of HIV-1 gag expression vector HXB2 pGag-EGFP.
APH-2 overexpression additionally inhibited the power of HIV-1 Tat to transactivate the HIV-1 LTR-driven expression of luciferase. Moreover, the introduction of mutations within the IXXLL motif on the N-terminal area of APH-2 reverted the inhibitory impact on HIV-1 Tat-mediated transcription, suggesting the attainable function of this motif in the direction of the downregulation of Tat-mediated transactivation.
General, these findings point out that the HTLV-2 APH-2 could have an effect on the HIV-1 replication at a number of ranges by (a) inhibiting the Tat-mediated transactivation and (b) hampering the virus launch by affecting the mobile gag expression.
An Epitope Platform for Protected and Efficient HTLV-1-Immunization: Potential Purposes for mRNA and Peptide-Based mostly Vaccines
Human T-cell lymphotropic virus kind 1 (HTLV-1) an infection impacts hundreds of thousands of people worldwide and might result in extreme leukemia, myelopathy/tropical spastic paraparesis, and quite a few different issues.
Pursuing a protected and efficient immunotherapeutic method, we in contrast the viral polyprotein and the human proteome with a sliding window method with a view to determine oligopeptide sequences distinctive to the virus. The immunological relevance of the viral distinctive oligopeptides was assessed by looking out them within the immune epitope database (IEDB). We discovered that HTLV-1 has 15 peptide stretches every consisting of uniquely viral non-human pentapeptides that are ideally suited candidate for a protected and efficient anti-HTLV-1 vaccine.
HTLV-1 gp21 recombinant protein |
00700-V-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: HTLV-1 gp21 recombinant protein |
Recombinant HTLV gp21 Protein (Coating) [2B3A] |
VAng-Lsx0306-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV gp21 Antigen [2B3A], Recombinant antigen. |
Recombinant HTLV gp21 Protein (Detection) [PV112] |
VAng-Lsx0307-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV gp21 Antigen [PV112], Recombinant antigen. |
Recombinant HIV HTLV-1 gp21 Protein, GST, E.coli-1mg |
QP12354-1mg |
EnQuireBio |
1mg |
EUR 1513.2 |
Recombinant HIV HTLV-1 gp21 Protein, GST, E.coli-100ug |
QP12354-100ug |
EnQuireBio |
100ug |
EUR 261.6 |
Recombinant HIV HTLV-1 gp21 Protein, GST, E.coli-500ug |
QP12354-500ug |
EnQuireBio |
500ug |
EUR 795.6 |
HTLV1 gp21 protein |
30-044001 |
Fitzgerald |
100 ug |
EUR 758.4 |
Description: Purified recombinant HTLV1 gp21 protein |
HTLV1 gp21 protein |
30-044001-LQ |
Fitzgerald |
100 ug |
EUR 758.4 |
Description: Purified recombinant HTLV1 gp21 protein |
HTLV1 gp21 protein (HRP) |
65-044002 |
Fitzgerald |
50 ug |
EUR 853.2 |
Description: Purified recombinant HTLV1 gp21 (HRP) |
HTLV-1 gp46 Protein |
20-abx260285 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1930.80
|
|
|
HTLV1 gp21 protein (FITC) |
65-044003 |
Fitzgerald |
50 ug |
EUR 418.8 |
Description: Purified recombinant HTLV1 gp21 (FITC) |
HTLV-1 gp46 recombinant protein |
00701-V-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: HTLV-1 gp46 recombinant protein |
HTLV-1 gp46 recombinant protein |
00701-V-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: HTLV-1 gp46 recombinant protein |
HTLV-1 gp46 recombinant protein |
00701-V-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
Description: HTLV-1 gp46 recombinant protein |
HTLV I gp46 Protein |
abx060599-100ug |
Abbexa |
100 ug |
EUR 811.2 |
|
Recombinant HIV HTLV-1 gp46 mosaic Protein, Untagged, E.coli-1mg |
QP12355-1mg |
EnQuireBio |
1mg |
EUR 1513.2 |
Recombinant HIV HTLV-1 gp46 mosaic Protein, Untagged, E.coli-100ug |
QP12355-100ug |
EnQuireBio |
100ug |
EUR 261.6 |
Recombinant HIV HTLV-1 gp46 mosaic Protein, Untagged, E.coli-500ug |
QP12355-500ug |
EnQuireBio |
500ug |
EUR 795.6 |
HTLV-1 p24 Protein |
20-abx260271 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1930.80
|
|
|
HTLV-1 TAX Antibody |
20-abx137064 |
Abbexa |
|
|
|
HTLV-1 Mosaic Protein |
20-abx260286 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1930.80
|
|
|
HTLV-1 Envelope Protein |
20-abx260142 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1646.40
|
|
|
Recombinant HTLV-1 Protein |
VAng-Lsx0308-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV type 1, recombinant protein from E. coli. |
Recombinant HTLV-1 Envelope |
7-07753 |
CHI Scientific |
100µg |
Ask for price |
Recombinant HTLV-1 Envelope |
7-07754 |
CHI Scientific |
500µg |
Ask for price |
Recombinant HTLV-1 Envelope |
7-07755 |
CHI Scientific |
1000µg |
Ask for price |
HTLV 1 ELISA Kit |
VArk-Lsx012 |
Creative Biolabs |
1 KIT |
Ask for price |
Description: Used for analyzing the presence of the human T-Cell lymphotropic viruses. |
HTLV-1 Tax (11-19) |
H-6096.0001 |
Bachem |
1.0mg |
EUR 138 |
Description: Sum Formula: C56H79N9O12; CAS# [141677-18-1] net |
HTLV-1 Tax (11-19) |
H-6096.0005 |
Bachem |
5.0mg |
EUR 441.6 |
Description: Sum Formula: C56H79N9O12; CAS# [141677-18-1] net |
Rat HTLV-1 ELISA Kit |
ERH0319 |
Abclonal |
96Tests |
EUR 625.2 |
Goat HTLV-1 ELISA Kit |
EGTH0319 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse HTLV-1 ELISA Kit |
EMH0319 |
Abclonal |
96Tests |
EUR 625.2 |
Human HTLV-1 ELISA Kit |
EHH0319 |
Abclonal |
96Tests |
EUR 625.2 |
HTLV-1 p24 Core Protein |
20-abx260143 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1646.40
|
|
|
Rabbit HTLV-1 ELISA Kit |
ERTH0319 |
Abclonal |
96Tests |
EUR 625.2 |
Bovine HTLV-1 ELISA Kit |
EBH0319 |
Abclonal |
96Tests |
EUR 625.2 |
Canine HTLV-1 ELISA Kit |
ECH0319 |
Abclonal |
96Tests |
EUR 625.2 |
Porcine HTLV-1 ELISA Kit |
EPH0319 |
Abclonal |
96Tests |
EUR 625.2 |
Anserine HTLV-1 ELISA Kit |
EAH0319 |
Abclonal |
96Tests |
EUR 625.2 |
Recombinant HTLV-1 p24 Core |
7-07756 |
CHI Scientific |
100µg |
Ask for price |
Recombinant HTLV-1 p24 Core |
7-07757 |
CHI Scientific |
500µg |
Ask for price |
Recombinant HTLV-1 p24 Core |
7-07758 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant HTLV-1 E Protein |
VAng-Lsx0321-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV type 1 Envelope, recombinant protein from E. coli. |
HTLV 1/2 ELISA Kit |
VArk-Lsx011 |
Creative Biolabs |
1 KIT |
Ask for price |
Description: Used for analyzing the presence of the human T-Cell lymphotropic viruses. |
Recombinant HTLV-1 Mosaic Protein |
VAng-Lsx0310-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV type 1 Mosaic Protein, recombinant protein from E. coli. |
Recombinant HTLV-1 E 701 Protein |
VAng-Lsx0322-50g |
Creative Biolabs |
50 µg |
EUR 2104.8 |
Description: HTLV type 1 Envelope 701, recombinant protein from E. coli. |
Guinea Pig HTLV-1 ELISA Kit |
EGH0319 |
Abclonal |
96Tests |
EUR 625.2 |
Recombinant HTLV-1 gp 46 Protein |
VAng-Lsx0319-100g |
Creative Biolabs |
100 µg |
EUR 2212.8 |
Description: HTLV type 1 Glycoprotein 46, recombinant protein from E. coli. |
Recombinant HTLV-1 gag p19 Protein |
VAng-Lsx7388-100g |
Creative Biolabs |
100 µg |
EUR 2193.6 |
Description: HTLV type 1 gag p19, recombinant protein from yeast. |
Recombinant HTLV-1 P24 Protein [His] |
VAng-Lsx0314-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 1126.8 |
Description: HTLV-1 P24 Protein [His], recombinant protein from E. coli. |
Recombinant HTLV-1 P24 Core Protein |
VAng-Lsx0313-100g |
Creative Biolabs |
100 µg |
EUR 975.6 |
Description: HTLV type 1 P24 Core, recombinant protein from E. coli. |
Recombinant HTLV-1 P24 Core Protein |
VAng-Lsx0313-1mg |
Creative Biolabs |
1 mg |
EUR 4104 |
Description: HTLV type 1 P24 Core, recombinant protein from E. coli. |
Tax9, HTLV 1 (11 19) Peptide |
20-abx266138 |
Abbexa |
-
EUR 493.20
-
EUR 794.40
-
EUR 376.80
|
|
|
HTLV-1 virus mosaic recombinant antigen |
00205-V-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: HTLV-1 virus mosaic recombinant antigen a.a. 374-400/190-207. |
HTLV-1 virus mosaic recombinant antigen |
00205-V-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: HTLV-1 virus mosaic recombinant antigen a.a. 374-400/190-207. |
Recombinant HTLV-2 Protein |
VAng-Lsx0309-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV type 2, recombinant protein from E. coli. |
Recombinant (E.Coli, GST tag) HTLV-1 Mosaic |
RP-578 |
Alpha Diagnostics |
100 ug |
EUR 343.2 |
HTLV I p24 Protein |
abx060600-1mg |
Abbexa |
1 mg |
EUR 1779.6 |
|
HTLV-I Env. Protein |
abx060597-1mg |
Abbexa |
1 mg |
EUR 1612.8 |
|
Human T-Lymphotropic Virus 1 (HTLV-1) ELISA Kit |
abx052972-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Recombinant HTLV P24 Protein |
VAng-Lsx0305-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV P24, recombinant protein from E. coli. |
Recombinant HTLV-2 E 802 Protein |
VAng-Lsx0328-50g |
Creative Biolabs |
50 µg |
EUR 2004 |
Description: HTLV-2 Envelope 802 Protein, recombinant protein from E. coli. |
Recombinant HTLV-1 gp 46 Protein (aa 165-440) |
VAng-Lsx0320-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV type 1 Glycoprotein 46 (aa 165-440), recombinant protein from E. coli. |
Recombinant HTLV-1 E Protein Protein (aa 165-440) |
VAng-Lsx0317-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV type 1 Envelope protein (aa 165-440), recombinant protein from E. coli. |
Recombinant HTLV-1 Active p24 Protein (aa 314-344) |
VAng-Lsx0318-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV type 1 Active p24 (aa 314-344), recombinant protein from E. coli. |
Recombinant HTLV-1 gp 21 Protein (aa 351-404) [GST] |
VAng-Lsx0315-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV type 1 Glycoprotein 21 (aa 351-404) [GST], recombinant protein from E. coli. |
Recombinant HTLV-1 gp 46 Protein (aa 165-440) [His] |
VAng-Lsx0316-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV type 1 Glycoprotein 46 (aa 165-440) [His], recombinant protein from E. coli. |
Human T-Lymphotropic Virus 1+2 (HTLV-1/2) ELISA Kit |
abx055384-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Recombinant HIV HTLV-1 p24 Protein, Untagged, E.coli-1mg |
QP12357-1mg |
EnQuireBio |
1mg |
EUR 1513.2 |
Recombinant HTLV-1 Mosiac Protein (aa 374-400, 190-207) |
VAng-Lsx0312-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV type 1 Mosiac (aa 374-400, 190-207), recombinant protein from E. coli. |
Recombinant HTLV Mosaic Protein [GST] |
VAng-Lsx0304-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Recombinant HTLV protein fused with GST at N-terminus was expressed in E. coli and purified by proprietary chromatographic technique. |
Recombinant HIV HTLV-1 p24 Protein, Untagged, E.coli-100ug |
QP12357-100ug |
EnQuireBio |
100ug |
EUR 261.6 |
Recombinant HIV HTLV-1 p24 Protein, Untagged, E.coli-500ug |
QP12357-500ug |
EnQuireBio |
500ug |
EUR 795.6 |
Recombinant HIV HTLV-1 mosaic Protein, Untagged, E.coli-1mg |
QP12356-1mg |
EnQuireBio |
1mg |
EUR 1513.2 |
HTLV-I Envelope Recombinant Antigen |
00203-V-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: HLTV-I envelope recombinant antigen. C-terminus of gp-46 and most of p21. |
HTLV-I Envelope Recombinant Antigen |
00203-V-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: HLTV-I envelope recombinant antigen. C-terminus of gp-46 and most of p21. |
Recombinant HIV HTLV-1 Envelope Protein, Untagged, E.coli-1mg |
QP12353-1mg |
EnQuireBio |
1mg |
EUR 1273.2 |
Recombinant HIV HTLV-1 mosaic Protein, Untagged, E.coli-100ug |
QP12356-100ug |
EnQuireBio |
100ug |
EUR 261.6 |
Recombinant HIV HTLV-1 mosaic Protein, Untagged, E.coli-500ug |
QP12356-500ug |
EnQuireBio |
500ug |
EUR 795.6 |
Recombinant HTLV-1 gp 46 Protein (aa 162-214, 242-257) |
VAng-Lsx0311-100g |
Creative Biolabs |
100 µg |
EUR 804 |
Description: HTLV type 1 Glycoprotein 46 (aa 162-214, 242-257), recombinant protein from E. coli. |
Recombinant HTLV-1 gp 46 Protein (aa 162-214, 242-257) |
VAng-Lsx0311-1mg |
Creative Biolabs |
1 mg |
EUR 4075.2 |
Description: HTLV type 1 Glycoprotein 46 (aa 162-214, 242-257), recombinant protein from E. coli. |
Recombinant HTLV-1 gp 46 Protein (aa 162-214, 242-257) |
VAng-Lsx0311-500g |
Creative Biolabs |
500 µg |
EUR 2144.4 |
Description: HTLV type 1 Glycoprotein 46 (aa 162-214, 242-257), recombinant protein from E. coli. |
Recombinant HIV HTLV-1 Envelope Protein, Untagged, E.coli-100ug |
QP12353-100ug |
EnQuireBio |
100ug |
EUR 261.6 |
Recombinant HIV HTLV-1 Envelope Protein, Untagged, E.coli-500ug |
QP12353-500ug |
EnQuireBio |
500ug |
EUR 795.6 |
HTLV1 gp46 protein |
30-041001 |
Fitzgerald |
100 ug |
EUR 548.4 |
Description: Purified recombinant HTLV1 gp46 protein |
HTLV1 gp46 protein |
30-042001F |
Fitzgerald |
1 mg |
EUR 418.8 |
Description: Purified recombinant HTLV1 protein (gp46) |
HTLV1 gp46 protein |
30-043001F |
Fitzgerald |
100 ug |
EUR 770.4 |
Description: Purified recombinant HTLV1 gp46 protein |
Recombinant HIV HTLV-1 p24 core Protein, Untagged, E.coli-1mg |
QP12358-1mg |
EnQuireBio |
1mg |
EUR 1273.2 |
HTLV-I p24 core recombinant antigen |
00204-V-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: HLTV-I p24 core recombinant antigen. |
HTLV-I p24 core recombinant antigen |
00204-V-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: HLTV-I p24 core recombinant antigen. |
Recombinant HTLV gp 46 Mosaic Protein |
VAng-Lsx0303-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Recombinant HTLV gp46 protein containing the gp46 immunodominant regions, 162-214 amino acids and 242-257 amino acids was expressed in E. coli and purified by proprietary chromatographic technique. |
HTLV-1 virus mosaic recombinant antigen a.a. 374-400/190-207. |
00205-V-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: HTLV-1 virus mosaic recombinant antigen a.a. 374-400/190-207. |
Recombinant HIV HTLV-1 p24 core Protein, Untagged, E.coli-100ug |
QP12358-100ug |
EnQuireBio |
100ug |
EUR 261.6 |
Recombinant HIV HTLV-1 p24 core Protein, Untagged, E.coli-500ug |
QP12358-500ug |
EnQuireBio |
500ug |
EUR 795.6 |
HTLV p19 Antigen ELISA (96 Determinations) |
0801116 |
Zeptometrix |
96T |
EUR 774 |
HTLV p19 Antigen ELISA (96 Determinations) |
801116 |
Zeptometrix |
96 Determinations |
EUR 737 |
Recombinant HTLV-2 gp 4 Protein (Full Length) |
VAng-Lsx0323-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 4202.4 |
Description: HTLV-2 gp 4 Protein, recombinant protein from E. coli. |
Recombinant HTLV-2 gp 4 Protein (Full Length) |
VAng-Lsx0323-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 2840.4 |
Description: HTLV-2 gp 4 Protein, recombinant protein from E. coli. |
Recombinant HTLV-2 gp 4 Protein (Full Length) |
VAng-Lsx0323-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 1941.6 |
Description: HTLV-2 gp 4 Protein, recombinant protein from E. coli. |
Recombinant HTLV-2 gp 2 Protein (Full Length) |
VAng-Lsx0324-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 6237.6 |
Description: HTLV-2 gp 2 Protein, recombinant protein from E. coli. |
Recombinant HTLV-2 gp 2 Protein (Full Length) |
VAng-Lsx0324-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 4215.6 |
Description: HTLV-2 gp 2 Protein, recombinant protein from E. coli. |
Recombinant HTLV-2 gp 2 Protein (Full Length) |
VAng-Lsx0324-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 3052.8 |
Description: HTLV-2 gp 2 Protein, recombinant protein from E. coli. |
Recombinant HTLV-2 gp 5 Protein (Full Length) |
VAng-Lsx0326-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 5437.2 |
Description: HTLV-2 gp 5 Protein, recombinant protein from E. coli. |
Recombinant HTLV-2 gp 5 Protein (Full Length) |
VAng-Lsx0326-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 3682.8 |
Description: HTLV-2 gp 5 Protein, recombinant protein from E. coli. |
Recombinant HTLV-2 gp 5 Protein (Full Length) |
VAng-Lsx0326-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 2503.2 |
Description: HTLV-2 gp 5 Protein, recombinant protein from E. coli. |
Human T-lymphotropicvirus?,HTLV-?ELISA Kit |
201-12-1810 |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human T-Lymphotropic Virus (HTLV) ELISA Kit |
abx055772-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Recombinant HTLV-2 gp 63 E Protein (aa 19-438) |
VAng-Lsx0327-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 8737.2 |
Description: HTLV-2 Envelope glycoprotein gp63 (aa 19-438), recombinant protein from E. coli. |
Recombinant HTLV-2 gp 63 E Protein (aa 19-438) |
VAng-Lsx0327-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 5900.4 |
Description: HTLV-2 Envelope glycoprotein gp63 (aa 19-438), recombinant protein from E. coli. |
Recombinant HTLV-2 gp 63 E Protein (aa 19-438) |
VAng-Lsx0327-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 4005.6 |
Description: HTLV-2 Envelope glycoprotein gp63 (aa 19-438), recombinant protein from E. coli. |
Human T-lymphotropicvirusⅠ(HTLV-Ⅰ)ELISA Kit |
GA-E1826HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human T-lymphotropicvirusⅠ(HTLV-Ⅰ)ELISA Kit |
GA-E1826HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Recombinant HTLV-2 gp 2 Gag-Pro-Pol Polyprotein |
VAng-Lsx0325-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HTLV-2 gp 2 Gag-Pro-Pol Polyprotein, recombinant protein from E. coli. |
Human T-Lymphotropic Virus Type I (HTLV-I) Lysate (1 mg) |
801033 |
Zeptometrix |
HTLV-I |
EUR 2071 |
Human T-lymphotropicvirusâ… /II(HTLV-â… /II) antibody ELISA kit |
CSB-E14216h-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
Description: Qualitativeindirect ELISA kit for measuring Human T-lymphotropicvirusâ… /II (HTLV-â… /II) antibody in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human T-lymphotropicvirusâ… /II(HTLV-â… /II) antibody ELISA kit |
1-CSB-E14216h |
Cusabio |
-
EUR 1080.00
-
EUR 6571.20
-
EUR 3480.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Qualitativeindirect ELISA kit for measuring Human T-lymphotropicvirusâ… /II(HTLV-â… /II) antibody in samples from serum, plasma. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
SeroDetect HTLV Ab Verification Panel (5 X 1.5 mL) |
KZMC011 |
Zeptometrix |
5 X 1.5 mL |
EUR 334.56 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
Human T-Lymphotropic Virus Type I (HTLV-I) Culture Fluid (1 mL) |
0801033CF |
Zeptometrix |
HTLV-I |
EUR 327 |
Human T-cell lymphotropic Virus antibody, HTLV (1+2) Ab ELISA Kit |
DEIA079 |
Creative Diagnostics |
96T |
EUR 1026 |
Description: This ELISA kit is an enzyme-linked immunosorbent assay (ELISA) for qualitative detection of antibodies to Human T-Cell Lymphotropic Virus types 1 and/or 2 (HTLV-1/2) in human serum or plasma. It is intended for screening of blood donors and as an aid for the diagnosis of clinical conditions related to infection with HTLV-1 and/or HTLV-2. |
Anti-HTLV Type I gp46 Clone 68/4.11.21 (1 mg) |
0801118 |
Zeptometrix |
1 mg |
EUR 1985 |
Anti-HTLV Type II gp46 Clone 73/4.9.8 (1 mg) |
0801119 |
Zeptometrix |
1 mg |
EUR 1985 |
Anti-HTLV Type I gp46 Clone 67/5.5.13.1 (1 mg) |
0801127 |
Zeptometrix |
1 mg |
EUR 1985 |
Anti-HTLV Type I gp46 Clone 68/4.11.21 (1 mg) |
801118 |
Zeptometrix |
1 mg |
EUR 1890 |
Anti-HTLV Type II gp46 Clone 73/4.9.8 (1 mg) |
801119 |
Zeptometrix |
1 mg |
EUR 1890 |
Anti-HTLV Type I gp46 Clone 67/5.5.13.1 (1 mg) |
801127 |
Zeptometrix |
1 mg |
EUR 1890 |
Anti-HTLV Type I gp46 Clone 65/6C2.2.34 (1 mg) |
0801094 |
Zeptometrix |
1 mg |
EUR 1985 |
Anti-HTLV Type I gp46 Clone 65/6C2.2.34 (1 mg) |
801094 |
Zeptometrix |
1 mg |
EUR 1890 |
NATtrol Human T-Lymphotropic Virus (HTLV) Type I Stock (Qualitative) (1 mL) |
NATHTLVI-ST |
Zeptometrix |
1 mL |
EUR 1281 |
NATtrol Human T-Lymphotropic Virus (HTLV) Type II Stock (Qualitative) (1 mL) |
NATHTLVII-ST |
Zeptometrix |
1 mL |
EUR 1281 |
Tax8, HTLV - 1 (12 - 19) (AA: Leu-Phe-Gly-Tyr-Pro-Val-Tyr-Val) (MW: 957.15) |
SP-86611-1 |
Alpha Diagnostics |
1 mg |
EUR 196.8 |
Tax9, HTLV - 1 (11 - 19) (AA: Leu-Leu-Phe-Gly-Tyr-Pro-Val-Tyr-Val) (MW: 1070.31) |
SP-64011-5 |
Alpha Diagnostics |
5 mg |
EUR 270 |
Recombinant Human T-cell Lymphotropic Virus-I (HTLV-I), p24 Antigen |
DAG503 |
Creative Diagnostics |
1mg |
EUR 1444.8 |
Anti-HTLV Type I gp46 Clone 67/5.5.13.1 (100 µg) |
0801084 |
Zeptometrix |
100 µg |
EUR 292 |
Anti-HTLV Type I gp46 Clone 68/4.11.21 (100 µg) |
0801085 |
Zeptometrix |
100 µg |
EUR 292 |
Anti-HTLV Type II gp46 Clone 73/4.9.8 (100 µg) |
0801086 |
Zeptometrix |
100 µg |
EUR 292 |
Anti-HTLV Type I gp46 Clone 67/5.5.13.1 (100 µg) |
801084 |
Zeptometrix |
100 µg |
EUR 278 |
Anti-HTLV Type I gp46 Clone 68/4.11.21 (100 µg) |
801085 |
Zeptometrix |
100 µg |
EUR 278 |
Anti-HTLV Type II gp46 Clone 73/4.9.8 (100 µg) |
801086 |
Zeptometrix |
100 µg |
EUR 278 |
Anti-HTLV Type I gp46 Clone 65/6C2.2.34 (100 µg) |
0802004 |
Zeptometrix |
100 µg |
EUR 340.8 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
HTLVR sgRNA CRISPR Lentivector (Human) (Target 1) |
K1003602 |
ABM |
1.0 ug DNA |
EUR 184.8 |
HIV-1 gp120 |
E62H004 |
EnoGene |
100ug |
EUR 458.4 |
HIV-1 gp160 |
E62H00401 |
EnoGene |
100ug |
EUR 458.4 |
Certainly, experimentally validated HTLV-1 epitopes, as retrieved from the IEDB, include peptide sequences additionally current in an unlimited variety of human proteins, thus doubtlessly instituting the premise for cross-reactions. We discovered a possible for cross-reactivity between the virus and the human proteome and described an epitope platform for use with a view to keep away from it, thus acquiring efficient, particular, and protected immunization. Potential benefits for mRNA and peptide-based vaccine formulations are mentioned.